Medtech companies that want to stay on the leading edge need to be fast, proactive, informed, and adaptable. They need to be able to pivot their strategy at a moment’s notice and to avoid being blindsided by unexpected moves from competitors or regulators.
AlphaSense is a leading provider of market intelligence, including 10,000+ high-quality content sources from more than 1,500 leading research providers — all in a single platform. And with industry-leading AI and automation features, AlphaSense accelerates your research process, enhances the quality of insights, and gives you the competitive edge.
G2 has consistently rated AlphaSense a leader in market intelligence, and our clients include some of the biggest names in the medtech space.
How the Top Medtech Companies Use AlphaSense
Competitive Intelligence
AlphaSense surfaces all the competitive insights you need in one place so that you can easily benchmark against peers, find out about any emerging competitors, identify competitive risks, and be first to know of trials, new modalities, and deal announcements.
You can set customizable watchlists and real-time alerts for specific companies, disease areas, or therapeutics. You can also set real-time alerts for 510(k) filings, competitors’ earnings reports, topical broker research, and expert call transcripts — and then access them all in one platform.
To track product mentions, trial updates, and competitor earnings all in one place — in a digestible, table format — use our Generative Grid feature.
“I found information [in AlphaSense] that I’ve never found anywhere else.”
– Head of Competitive Intelligence, CSL Behring
Corporate Development and M&A
AlphaSense allows you to get smart on an investment target, disease area, or market opportunity by using AI to find insights faster. With our Generative Grid feature, you can query specific prompts across multiple companies at the same time — and see results in a digestible, tabular format.
For example, let’s say you’re interested in how large healthcare firms are approaching their investments in smaller medtech companies. You can input a list of incumbent medtech conglomerates into Gen Grid and dive deep into their M&A strategy, including what types of companies are getting acquired or funded by whom.
"The AlphaSense platform’s advanced search and alert features keep us updated on relevant developments in real time. This capability enables us to respond with agility and confidence to opportunities in our field."
– Senior Manager of Corporate Development, Theramex
Corporate Strategy
AlphaSense helps you scan new disease areas, validate market opportunities, and shape portfolio bets — all in one platform, in minutes.
Monitor specific subsectors of the medtech industry by searching those topics on the platform and seeing how the keywords have trended over time. Take it a step further further by leveraging our Generative Search (now with Deep Research) feature, where you can ask a natural language question about any company or topic, and get a detailed verifiable response back. For example, you can use Generative Search to develop a detailed landscape overview of market dynamics, key players, and competitive pressures for any specific disease or therapeutic area.
Investor Relations
AlphaSense helps you craft narratives that align with market tone, sentiment, and peer benchmarks. Use our genAI features like Generative Grid and Generative Search to compare competitor narratives and prep for Q&A. Use our sentiment analysis feature to easily monitor real-time sentiment in earnings calls and expert interview transcripts.
"The time saved by using AlphaSense is enormous. It easily saves us several hours a week. Requested information can be prepared in a timely, precise and efficient manner. For our daily work, this is essential."
– Michael Otto, Director of Investor Relations and Sustainability at Fresenius Group
Commercialization
If you are interested in commercializing a product, device, or technology, AlphaSense can help you extract market data from qualitative sources to develop TAM analyses, evaluate market opportunities to forecast sales, and develop go-to market strategies.
AlphaSense also allows you to find answers to key questions during commercialization:
- Is the concept novel and validated? To answer this, you need to evaluate the market landscape — what kinds of companies are in this space, what technologies are being used, what are the health systems using this tech, what other companies have tried bringing a similar product to market in the past, and what do experts say about similar devices or technologies?
- Has the concept cleared the regulatory and FDA requirements? For this, you can consult the regulatory documents such as 510(k) filings and European Medicines Agency documents, all housed on the AlphaSense platform.
- Is your product faster, better, or more cost-effective than competitors’? For this, you can rely on competitive signals and M&A tracking, so you can always be aware of key factors such as a huge incumbent buying a company making a similar product, health system/consumer spending in a potential target market, and what pricing and profitability look like for similar technology.
Another important consideration in commercialization is the possibility of partnering with a biopharma company or health system in order to lower cost or expand reach. For this, you must use a tool that enables you to conduct in-depth research on public and private companies.
What Our Clients Are Saying
“GenGrid lets us quickly evaluate clinical performance metrics side-by-side. It’s an absolute must-have tool for competitive benchmarking in Life Sciences.”
– VP of Competitive Strategy, Global Pharmaceutical Company
"The ability to instantly benchmark our competitors’ pipelines and commercial strategies has significantly enhanced our strategic planning process."
– Senior Competitive Intelligence Manager, Biotech Firm
"Using GenSearch, we quickly pinpoint growth drivers and risks in emerging therapeutic areas, making diligence faster and sharper."
– Head of Strategic Investments, Leading Biotech Firm
"AlphaSense lets us do deep, consultant-quality industry assessments internally, accelerating our corporate development process significantly."
– VP Corporate Development, Global Life Sciences Company
"GenGrid’s ability to instantly surface competitor insights on clinical trials, commercialization strategies, and regulatory positioning has become critical to our early-stage diligence process.”
– Senior Analyst, Corporate Development, Fortune 500 Pharma Company
Accelerate Your Research Process with AlphaSense
AlphaSense aggregates all the essential market research perspectives you need in one place, so you can have a complete picture of the company profiles, markets, or trends you are researching.
Combined with proprietary AI and automation functionality not found on other platforms, AlphaSense helps you dramatically increase the breadth, depth, and accuracy of your research.
Here’s what you get when you use the AlphaSense platform for your market intelligence:
Aggregated Market Research
AlphaSense houses a vast universe of over 10,000 trusted content sources, including but not limited to:
- Healthcare news, industry reports, company reports, clinical trial updates and regulatory content from sources such as PubMed, ClinicalTrials.gov, World Health Organization, MedlinePlus, and FDA
- Over 1,500 research providers including Wall Street Insights®, a premier analyst research collection for corporate professionals
- Expert call transcript library with over 200,000 vetted interviews (including with competitors, suppliers, doctors, and KOLs)
Our platform not only houses all of the content you need to make rapid data-driven decisions, it also helps you cut through the noise with advanced search functionality.
Enterprise Intelligence
AlphaSense’s Enterprise Intelligence solution allows you to integrate and query your own internal content alongside the premium external sources listed above. That includes:
- Internal research, notes, and presentations
- CIMs and investment memos
- Reports from industry and market intelligence providers
- Emails, newsletters, web pages, and RSS feeds
In this way, AlphaSense centralizes all your internal and external knowledge in one place, and allows you to leverage our industry-leading search, summarization, and monitoring tools to enhance and accelerate your research.
Our genAI capabilities deliver instant, accurate, and secure summarizations with the ability to ask follow-up questions across both your proprietary internal content and hundreds of millions of premium external documents.
AI Search & Summarization Technology
AlphaSense has invested 10+ years into the development of our tech stack. Our industry-leading suite of AI tools is purpose-built to deliver business-grade insights:
Generative Search
Generative Search, now with Deep Research capabilities, transforms how users can extract insights from our vast library of premium content sources. Generative Search is trained to think like an analyst, so it understands the market research intent behind your natural language queries.
When searching for insights, Generative Search helps you get up to speed on a company or topic by instantly surfacing the answers you need. You can dig deeper into topics by asking follow-up questions or choosing a suggested query. Each answer provides citations to the exact snippet of text from where the information was sourced, so that it can always be referenced back..
Generative Grid
Generative Grid applies multiple genAI prompts across many documents at the same time to quickly provide organized answers to research questions at scale, in an easy-to-read table format. You can use GenGrid to build living matrices that track PBM mentions, market access, and competitive response.
Generative Grid pulls data from both premium external documents in the AlphaSense platform and users’ internal content. From there, users can choose pre-built templates or create their own to automate routine workflows. Each summary provides a direct citation to the source material it was pulled from.
Smart Summaries
This feature allows you to glean instant earnings insights (reducing time spent on research during earnings season), quickly capture company outlook and bull/bear cases from analyst research, and generate an expert-approved SWOT analysis straight from former competitors, partners, and employees. All Summaries provide you with citations to the exact snippets of text from where the summaries are sourced — combining high accuracy with easy verification.
Smart Synonyms
This unique feature is proprietary to AlphaSense and has the ability to understand both the keyword and search intent behind any of your queries, factoring in search results that include variations in business language. For example, a search for “TAM” will also bring back results on “addressable market” and “market size.”
Sentiment Analysis
Sentiment Analysis, a natural language processing (NLP)-based feature, parses through content and identifies nuances in the tone and subjective meaning of text. It then uses color coding to help readers identify the document’s positive, negative, and neutral sentiments.
This technology assigns each search term a numerical sentiment change score to help users track any slight change in market sentiment over time. Users can take advantage of it to make better-informed investment decisions and improve risk management strategies.
Medtech Industry Insights from the AlphaSense Platform:
Analyzing Expert Transcripts: 4 Trending Conversations in Medtech
This post provides a snapshot of the most pertinent MedTech conversations available in our expert call database.
Tracking the Next M&A Deal: 16 Medtech Companies to Watch
We identified the top MedTech companies you should keep an eye on, based on recent product developments, growth, and margins.
How Leading Healthcare Companies Are Using AI to Get Ahead
Learn how life science and healthcare companies are increasingly tapping into the power of AI to conduct better, faster research and gain the competitive edge.
Fortune 500 Medical Device Company – Corporate Strategy Case Study
Read about how a Fortune 500 medical device leader uses AlphaSense to produce higher quality analysis.
Fresenius Group – Investor Relations Case Study
Read about how Fresenius Group makes IR work more efficient with AlphaSense.
Frequently Asked Questions
Some of the top trends in the medtech sector right now are:
- Expansion of artificial intelligence in planning, procedures, and diagnostics
- Continued rise in use of telemedicine and digital therapeutics
- Continued rise in use of wearable and biometric technology
- Continued expansion of personalized and precision medicine
- Heightened cybersecurity, privacy, and regulatory pressures
For additional trends, read Medtech Trends & Outlook.
